{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:06:12Z","timestamp":1787313972678,"version":"build-2736575974"},"reference-count":139,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14674","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:16:57Z","timestamp":1725610617000},"source":"Crossref","is-referenced-by-count":3,"title":["Advances in the study of the mechanism of action of miR\u201122 in liver lesions (Review)"],"prefix":"10.3892","volume":"28","author":[{"given":"Minghe","family":"Wang","sequence":"first","affiliation":[{"name":"College of Second Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Second Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikuo","family":"Gai","sequence":"additional","affiliation":[{"name":"College of Second Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingran","family":"Ye","sequence":"additional","affiliation":[{"name":"College of Second Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Second Clinical Medical, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"You","sequence":"additional","affiliation":[{"name":"Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"key20241003102830_b1-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"key20241003102830_b2-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 Update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"key20241003102830_b3-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/JHC.S238963","article-title":"Rare site hepatocellular carcinoma metastasis","volume":"7","author":"Boldo","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"key20241003102830_b4-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.cgh.2023.01.039","article-title":"Breakthroughs in hepatocellular carcinoma therapies","volume":"21","author":"Singal","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20241003102830_b5-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"e14351","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol Med"},{"key":"key20241003102830_b6-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4254\/wjh.v7.i9.1157","article-title":"Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome","volume":"7","author":"Bodzin","year":"2015","journal-title":"World J Hepatol"},{"key":"key20241003102830_b7-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3748\/wjg.v20.i1.142","article-title":"Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20241003102830_b8-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.3748\/wjg.v21.i18.5695","article-title":"Prevalence of fatty liver disease and the economy in China: A systematic review","volume":"21","author":"Zhu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20241003102830_b9-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12072-020-10023-3","article-title":"The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: A meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"key20241003102830_b10-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"key20241003102830_b11-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"key20241003102830_b12-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"107237","DOI":"10.18632\/oncotarget.20883","article-title":"Prognostic value of microRNAs in hepatocellular carcinoma: A meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"key20241003102830_b13-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.ymthe.2023.04.019","article-title":"miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism","volume":"31","author":"Hu","year":"2023","journal-title":"Mol Ther"},{"key":"key20241003102830_b14-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ymthe.2021.04.011","article-title":"TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p","volume":"29","author":"Song","year":"2021","journal-title":"Mol Ther"},{"key":"key20241003102830_b15-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.3390\/ijms231911502","article-title":"miRNA: A promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20241003102830_b16-ol-28-5-14674","first-page":"83","article-title":"MicroRNAs: Processing, maturation, target recognition and regulatory functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol Cell Pharmacol"},{"key":"key20241003102830_b17-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"e0281536","DOI":"10.1371\/journal.pone.0281536","article-title":"Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration\/invasion by indirectly regulating SPRY2","volume":"18","author":"Cui","year":"2023","journal-title":"PLoS One"},{"key":"key20241003102830_b18-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"937","DOI":"10.29271\/jcpsp.2021.08.937","article-title":"MiR-22-3p suppresses cell migration and invasion by targeting PLAGL2 in breast cancer","volume":"31","author":"Fan","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"key":"key20241003102830_b19-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10142-023-01211-z","article-title":"MiR-22-3p suppresses NSCLC cell migration and EMT via targeting RAC1 expression","volume":"23","author":"Wang","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"key20241003102830_b20-ol-28-5-14674","first-page":"278","article-title":"miR-22-3p suppresses cell proliferation and migration of gastric cancer by targeting ENO1","volume":"29","author":"Qiao","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"key20241003102830_b21-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"key20241003102830_b22-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/21691401.2019.1703723","article-title":"The expression level and diagnostic value of microRNA-22 in HCC patients","volume":"48","author":"Zeng","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"key20241003102830_b23-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"12870","DOI":"10.3390\/ijms241612870","article-title":"MicroRNA-22 is a key regulator of lipid and metabolic homeostasis","volume":"24","author":"Panella","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20241003102830_b24-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1177\/15353702221108379","article-title":"MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3","volume":"247","author":"Wang","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20241003102830_b25-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.molmet.2020.101087","article-title":"Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53\/miRNA-22\/SIRT1\/PPAR\u03b1 dependent","volume":"42","author":"Azar","year":"2020","journal-title":"Mol Metab"},{"key":"key20241003102830_b26-ol-28-5-14674","first-page":"4932","article-title":"Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1","volume":"8","author":"Chen","year":"2016","journal-title":"Am J Transl Res"},{"key":"key20241003102830_b27-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/15384101.2021.1875665","article-title":"LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3","volume":"20","author":"Huang","year":"2021","journal-title":"Cell Cycle"},{"key":"key20241003102830_b28-ol-28-5-14674","first-page":"5012648","article-title":"Plasma miR-22-5p, miR-132-5p, and miR-150-3p are associated with acute myocardial infarction","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"key":"key20241003102830_b29-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1002\/jcp.27274","article-title":"Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"key20241003102830_b30-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","article-title":"LncRNA-mediated regulation of cell signaling in cancer","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"key":"key20241003102830_b31-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-020-01174-w","article-title":"MIR22HG acts as a tumor suppressor via TGFbeta\/SMAD signaling and facilitates immunotherapy in colorectal cancer","volume":"19","author":"Xu","year":"2020","journal-title":"Mol Cancer"},{"key":"key20241003102830_b32-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"13108","DOI":"10.1080\/21655979.2022.2079244","article-title":"Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"key20241003102830_b33-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41419-021-04105-9","article-title":"MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis"},{"key":"key20241003102830_b34-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-020-01784-8","article-title":"Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers","volume":"39","author":"Zhang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"key20241003102830_b35-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","article-title":"microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity","volume":"103","author":"Zhang","year":"2010","journal-title":"Br J Cancer"},{"key":"key20241003102830_b36-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1074\/jbc.M114.620369","article-title":"MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor","volume":"290","author":"Yang","year":"2015","journal-title":"J Biol Chem"},{"key":"key20241003102830_b37-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7150\/jca.79475","article-title":"Long noncoding RNA DSCR8 promotes the proliferation of liver cancer cells and inhibits apoptosis via the miR-22-3p\/ARPC5 axis","volume":"14","author":"Huang","year":"2023","journal-title":"J Cancer"},{"key":"key20241003102830_b38-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"80751","DOI":"10.18632\/oncotarget.13037","article-title":"miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"key20241003102830_b39-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/cells11182860","article-title":"MiR-22 deficiency fosters hepatocellular carcinoma development in fatty liver","volume":"11","author":"Gjorgjieva","year":"2022","journal-title":"Cells"},{"key":"key20241003102830_b40-ol-28-5-14674","first-page":"2159","article-title":"MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2","volume":"11","author":"Zhang","year":"2021","journal-title":"Am J Cancer Res"},{"key":"key20241003102830_b41-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yexmp.2019.104265","article-title":"Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p\/MTA3 signalling in hepatocellular carcinoma","volume":"109","author":"Zhao","year":"2019","journal-title":"Exp Mol Pathol"},{"key":"key20241003102830_b42-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/cas.13950","article-title":"LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p\/NCOR2 axis in hepatocellular carcinoma cells","volume":"110","author":"Wu","year":"2019","journal-title":"Cancer Sci"},{"key":"key20241003102830_b43-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.7150\/thno.22493","article-title":"Identification and functional characterization of long non-coding RNA MIR22HG as a tumor suppressor for hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"key20241003102830_b44-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12935-016-0380-8","article-title":"The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147","volume":"17","author":"Luo","year":"2017","journal-title":"Cancer Cell Int"},{"key":"key20241003102830_b45-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/onc.2013.564","article-title":"Casein kinase 1 regulates sprouty2 in FGF-ERK signaling","volume":"34","author":"Yim","year":"2015","journal-title":"Oncogene"},{"key":"key20241003102830_b46-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat Rev Genet"},{"key":"key20241003102830_b47-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.18632\/aging.102240","article-title":"lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence","volume":"11","author":"Zhao","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"key20241003102830_b48-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.yexmp.2021.104638","article-title":"Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma","volume":"120","author":"Guo","year":"2021","journal-title":"Exp Mol Pathol"},{"key":"key20241003102830_b49-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/21655979.2021.2017565","article-title":"ETS proto-oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS proto-oncogene 1","volume":"13","author":"Pan","year":"2022","journal-title":"Bioengineered"},{"key":"key20241003102830_b50-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/tox.23160","article-title":"LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p\/BCL9 axis to activate the Wnt\/\u03b2-catenin signaling","volume":"36","author":"Guan","year":"2021","journal-title":"Environ Toxicol"},{"key":"key20241003102830_b51-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"110395","DOI":"10.1016\/j.biopha.2020.110395","article-title":"NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p\/IGF1R ceRNA pathway","volume":"129","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"key20241003102830_b52-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15403\/jgld-4077","article-title":"LncRNA NCK1-AS1 aggravates hepatocellular carcinoma by the miR-22-3p\/YARS axis to activate PI3K\/AKT signaling","volume":"31","author":"Zhou","year":"2022","journal-title":"J Gastrointestin Liver Dis"},{"key":"key20241003102830_b53-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00432-019-03115-7","article-title":"YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling","volume":"146","author":"Zhang","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20241003102830_b54-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol"},{"key":"key20241003102830_b55-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"75165","DOI":"10.18632\/oncotarget.12614","article-title":"Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"key20241003102830_b56-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"key20241003102830_b57-ol-28-5-14674","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"key20241003102830_b58-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"key20241003102830_b59-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.it.2021.09.005","article-title":"RORgammat protein modifications and IL-17-mediated inflammation","volume":"42","author":"Kumar","year":"2021","journal-title":"Trends Immunol"},{"key":"key20241003102830_b60-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1038\/s41388-021-01846-x","article-title":"Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy","volume":"40","author":"Lequeux","year":"2021","journal-title":"Oncogene"},{"key":"key20241003102830_b61-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression-implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"key20241003102830_b62-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"key20241003102830_b63-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hep.29106","article-title":"Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation","volume":"66","author":"Golden-Mason","year":"2017","journal-title":"Hepatology"},{"key":"key20241003102830_b64-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00262-023-03516-1","article-title":"TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors","volume":"72","author":"Sauer","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"key20241003102830_b65-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.intimp.2021.107933","article-title":"TIM-3: An update on immunotherapy","volume":"99","author":"Zhao","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"key20241003102830_b66-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3892\/or.2015.4167","article-title":"microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer","volume":"34","author":"Yang","year":"2015","journal-title":"Oncol Rep"},{"key":"key20241003102830_b67-ol-28-5-14674","first-page":"9632","article-title":"Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma","volume":"14","author":"Shao","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"key20241003102830_b68-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"key20241003102830_b69-ol-28-5-14674","first-page":"742","article-title":"Expression of microRNA-122 and microRNA-22 in HBV-related liver cancer and the correlation with clinical features","volume":"21","author":"Qiao","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20241003102830_b70-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijbiomac.2019.02.012","article-title":"Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma","volume":"129","author":"Ke","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"key20241003102830_b71-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.biopha.2013.03.002","article-title":"MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma","volume":"67","author":"Shi","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"key20241003102830_b72-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3892\/mmr.2021.12436","article-title":"FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt\/\u03b2-catenin signaling pathway","volume":"24","author":"Qian","year":"2021","journal-title":"Mol Med Rep"},{"key":"key20241003102830_b73-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3389\/fonc.2020.00903","article-title":"Downregulated FOXO3a associates with poor prognosis and promotes cell invasion and migration via WNT\/\u03b2-catenin signaling in cervical carcinoma","volume":"10","author":"Tian","year":"2020","journal-title":"Front Oncol"},{"key":"key20241003102830_b74-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"key20241003102830_b75-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ccr.2008.06.016","article-title":"Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis","volume":"14","author":"Sakurai","year":"2008","journal-title":"Cancer Cell"},{"key":"key20241003102830_b76-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1158\/1078-0432.CCR-10-1734","article-title":"miR-22 promotes HBV-related hepatocellular carcinoma development in males","volume":"17","author":"Jiang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20241003102830_b77-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1128\/MCB.01875-08","article-title":"miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA","volume":"29","author":"Pandey","year":"2009","journal-title":"Mol Cell Biol"},{"key":"key20241003102830_b78-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-017-0670-6","article-title":"EZH2 promotes hepatocellular carcinoma progression through modulating miR-22\/galectin-9 axis","volume":"37","author":"Chen","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"key20241003102830_b79-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1207496","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in HCC","volume":"14","author":"Guo","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20241003102830_b80-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2014.02.001","article-title":"Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes","volume":"269","author":"Cheng","year":"2014","journal-title":"J Neuroimmunol"},{"key":"key20241003102830_b81-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/1535-7163.MCT-12-0700","article-title":"Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo","volume":"12","author":"Portmann","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"key20241003102830_b82-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"572585","DOI":"10.3389\/fonc.2021.572585","article-title":"lncRNA MIR22HG-derived miR-22-5p enhances the radiosensitivity of hepatocellular carcinoma by increasing histone acetylation through the inhibition of HDAC2 activity","volume":"11","author":"Jin","year":"2021","journal-title":"Front Oncol"},{"key":"key20241003102830_b83-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12876-018-0893-9","article-title":"Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: A retrospective cross-sectional study","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"key20241003102830_b84-ol-28-5-14674","article-title":"Alpha-fetoprotein analysis. In: StatPearls [Internet]","author":"Adigun","year":"2024"},{"key":"key20241003102830_b85-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00261-022-03428-1","article-title":"An assessment of liver lesions using a combination of CEUS LI-RADS and AFP","volume":"47","author":"Li","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"key20241003102830_b86-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/17474124.2018.1512855","article-title":"Testing for AFP in combination with ultrasound improves early liver cancer detection","volume":"12","author":"Tzartzeva","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20241003102830_b87-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"12273","DOI":"10.1007\/s13277-016-5097-8","article-title":"Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection","volume":"37","author":"Zekri","year":"2016","journal-title":"Tumour Biol"},{"key":"key20241003102830_b88-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"197973","DOI":"10.1016\/j.virusres.2020.197973","article-title":"The HBx and HBc of hepatitis B virus can influence Id1 and Id3 by reducing their transcription and stability","volume":"284","author":"Xia","year":"2020","journal-title":"Virus Res"},{"key":"key20241003102830_b89-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"15658","DOI":"10.1038\/s41598-017-15594-0","article-title":"Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"key20241003102830_b90-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1002\/jmv.26916","article-title":"Baseline serum exosome-derived miRNAs predict HBeAg seroconversion in chronic hepatitis B patients treated with peginterferon","volume":"93","author":"Hu","year":"2021","journal-title":"J Med Virol"},{"key":"key20241003102830_b91-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): Functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"key20241003102830_b92-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"710285","DOI":"10.3389\/fphys.2021.710285","article-title":"Similarities and differences: A comparative review of the molecular mechanisms and effectors of NAFLD and AFLD","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Physiol"},{"key":"key20241003102830_b93-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.18632\/aging.203059","article-title":"Chronic alcohol exposure promotes HCC stemness and metastasis through \u03b2-catenin\/miR-22-3p\/TET2 axis","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"key20241003102830_b94-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/2211-5463.13026","article-title":"MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro","volume":"11","author":"Yang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"key20241003102830_b95-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"100093","DOI":"10.1016\/j.jhepr.2020.100093","article-title":"miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction","volume":"2","author":"Hu","year":"2020","journal-title":"JHEP Rep"},{"key":"key20241003102830_b96-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"key20241003102830_b97-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"key20241003102830_b98-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbadis.2017.11.026","article-title":"Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment","volume":"1864","author":"Agosti","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20241003102830_b99-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.3390\/ijms22115717","article-title":"Pathophysiological aspects of alcohol metabolism in the liver","volume":"22","author":"Hyun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20241003102830_b100-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon","year":"2020","journal-title":"J Lipid Res"},{"key":"key20241003102830_b101-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.canlet.2020.11.026","article-title":"FGF21 in obesity and cancer: New insights","volume":"499","author":"Lu","year":"2021","journal-title":"Cancer Lett"},{"key":"key20241003102830_b102-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"100918","DOI":"10.1016\/j.jhepr.2023.100918","article-title":"Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1","volume":"6","author":"Rodr\u00edguez-Agudo","year":"2023","journal-title":"JHEP Rep"},{"key":"key20241003102830_b103-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1111\/jcmm.13681","article-title":"Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis","volume":"22","author":"Iwagami","year":"2018","journal-title":"J Cell Mol Med"},{"key":"key20241003102830_b104-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"key20241003102830_b105-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cld.722","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases","volume":"11","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"key20241003102830_b106-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/cells12010169","article-title":"Exosomes from short-term high-fat or high-sucrose fed mice induce hepatic steatosis through different pathways","volume":"12","author":"Castano","year":"2022","journal-title":"Cells"},{"key":"key20241003102830_b107-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/nat.2019.0820","article-title":"Metabolic benefits of MicroRNA-22 inhibition","volume":"30","author":"Thibonnier","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"key20241003102830_b108-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"e001478","DOI":"10.1136\/bmjdrc-2020-001478","article-title":"Metabolic and energetic benefits of microRNA-22 inhibition","volume":"8","author":"Thibonnier","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"key20241003102830_b109-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/jpm10040170","article-title":"Genetic ablation of MiR-22 fosters diet-induced obesity and NAFLD development","volume":"10","author":"Gjorgjieva","year":"2020","journal-title":"J Pers Med"},{"key":"key20241003102830_b110-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"key20241003102830_b111-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","article-title":"MicroRNA-mediated regulation of glucose and lipid metabolism","volume":"22","author":"Agbu","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20241003102830_b112-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.2337\/db14-1924","article-title":"Elevated hepatic miR-22-3p expression impairs gluconeogenesis by silencing the Wnt-responsive transcription factor Tcf7","volume":"64","author":"Kaur","year":"2015","journal-title":"Diabetes"},{"key":"key20241003102830_b113-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"703170","DOI":"10.3389\/fendo.2021.703170","article-title":"3,5-Diiodo-L-thyronine (T2) administration affects visceral adipose tissue inflammatory state in rats receiving long-lasting high-fat diet","volume":"12","author":"Petito","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20241003102830_b114-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fphys.2018.00194","article-title":"3,5-Diiodo-L-thyronine affects structural and metabolic features of skeletal muscle mitochondria in high-fat-diet fed rats producing a co-adaptation to the glycolytic fiber phenotype","volume":"9","author":"Silvestri","year":"2018","journal-title":"Front Physiol"},{"key":"key20241003102830_b115-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"16645","DOI":"10.1038\/s41598-019-53019-2","article-title":"miR-22-3p is involved in gluconeogenic pathway modulated by 3,5-diiodo-L-thyronine (T2)","volume":"9","author":"Senese","year":"2019","journal-title":"Sci Rep"},{"key":"key20241003102830_b116-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"154771","DOI":"10.1016\/j.metabol.2021.154771","article-title":"Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist","volume":"119","author":"Zhao","year":"2021","journal-title":"Metabolism"},{"key":"key20241003102830_b117-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1756283X11413002","article-title":"Current status of novel antifibrotic therapies in patients with chronic liver disease","volume":"4","author":"Cohen-Naftaly","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"key20241003102830_b118-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20241003102830_b119-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"key20241003102830_b120-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"173507","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"key20241003102830_b121-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1111\/jcmm.16376","article-title":"Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN\/PI3K\/AKT pathway","volume":"25","author":"Riaz","year":"2021","journal-title":"J Cell Mol Med"},{"key":"key20241003102830_b122-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"109034","DOI":"10.1016\/j.intimp.2022.109034","article-title":"miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN\/PDGFR-\u03b2","volume":"110","author":"Chen","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"key20241003102830_b123-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/hepr.13758","article-title":"Circ_0011232 contributes to hepatocellular carcinoma progression through miR-503-5p\/AKT3 axis","volume":"52","author":"Ju","year":"2022","journal-title":"Hepatol Res"},{"key":"key20241003102830_b124-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"172659","DOI":"10.1016\/j.ejphar.2019.172659","article-title":"MiR-125b-5p and miR-181b-5p inhibit keratinocyte proliferation in skin by targeting Akt3","volume":"862","author":"Zheng","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"key20241003102830_b125-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-019-0302-2","article-title":"LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p\/AKT3 axis","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci"},{"key":"key20241003102830_b126-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.3390\/ijms23105420","article-title":"Green synthesis of silymarin-chitosan nanoparticles as a new nano formulation with enhanced anti-fibrotic effects against liver fibrosis","volume":"23","author":"Abdullah","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20241003102830_b127-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/biomedicines9121767","article-title":"Preparation and characterization of silymarin-conjugated gold nanoparticles with enhanced anti-fibrotic therapeutic effects against hepatic fibrosis in rats: Role of MicroRNAs as molecular targets","volume":"9","author":"Abdullah","year":"2021","journal-title":"Biomedicines"},{"key":"key20241003102830_b128-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"key":"key20241003102830_b129-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1159\/000430276","article-title":"MiR-22 suppresses BMP7 in the development of cirrhosis","volume":"36","author":"Ji","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"key20241003102830_b130-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"key":"key20241003102830_b131-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"key20241003102830_b132-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.gtc.2017.01.004","article-title":"Drug-induced liver injury: The hepatic pathologist's approach","volume":"46","author":"Kleiner","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"key20241003102830_b133-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"key20241003102830_b134-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s11010-020-03988-0","article-title":"MiR-122-5p knockdown protects against APAP-mediated liver injury through up-regulating NDRG3","volume":"476","author":"Yang","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"key20241003102830_b135-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1111\/bcp.13282","article-title":"MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury","volume":"83","author":"Vliegenthart","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"key20241003102830_b136-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.7150\/ijms.47766","article-title":"Characterization and functional prediction of the microRNAs differentially expressed in a mouse model of concanavalin A-induced autoimmune hepatitis","volume":"17","author":"Liu","year":"2020","journal-title":"Int J Med Sci"},{"key":"key20241003102830_b137-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphar.2017.00003","article-title":"New microRNA biomarkers for drug-induced steatosis and their potential to predict the contribution of drugs to non-alcoholic fatty liver disease","volume":"8","author":"L\u00f3pez-Riera","year":"2017","journal-title":"Front Pharmacol"},{"key":"key20241003102830_b138-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0034-1375960","article-title":"Drug-induced hepatic steatosis","volume":"34","author":"Amacher","year":"2014","journal-title":"Semin Liver Dis"},{"key":"key20241003102830_b139-ol-28-5-14674","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","article-title":"Drug-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv Pharmacol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:08:59Z","timestamp":1732723739000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":139,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,6]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14674","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"article-number":"541"}}